There is no FDA guidance on the use of Pregabalin in women of reproductive potentials and males. There is no FDA guidance on the use of Pregabalin in patients with hepatic impairment. There is no FDA guidance on the use of Pregabalin in patients with renal impairment.
- Pregabalin has potential for recreational use and abuse.citation needed It possesses a relatively wide therapeutic index and margin of safety compared to other central nervous system (CNS) depressants, and its effects may include euphoria, anxiolysis, and sedation.
- There is no FDA guidance one the use of Pregabalin in patients who are immunocompromised.
- There is limited information regarding Chronic Overdose of Pregabalin in the drug label.
Adjunctive Therapy for Adult Patients with Partial Onset Seizures
Lyrica’s US package insert recommends a taper period of at least one week.80 Best Practice Advocacy Centre New Zealand81 and NHS Somerset82 recommend a much slower withdrawal. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling.
Medical uses
There is limited information regarding Pharmacodynamics of Pregabalin in the drug label. There is limited information regarding Chronic Overdose of Pregabalin in the drug label. There is limited information regarding IV Compatibility of Pregabalin in the drug label. There is no FDA guidance one the use of Pregabalin in patients who are pregabalin wikipedia immunocompromised.
Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
- There is no FDA guidance on the use of Pregabalin in patients with hepatic impairment.
- There is limited information regarding Pharmacodynamics of Pregabalin in the drug label.
- Lyrica’s US package insert recommends a taper period of at least one week.80 Best Practice Advocacy Centre New Zealand81 and NHS Somerset82 recommend a much slower withdrawal.
- WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider.
- There is limited information regarding FDA-Labeled Use of Pregabalin in pediatric patients.
There is limited information regarding Off-Label Non–Guideline-Supported Use of Pregabalin in pediatric patients. There is limited information regarding Off-Label Guideline-Supported Use of Pregabalin in pediatric patients. There is limited information regarding FDA-Labeled Use of Pregabalin in pediatric patients. There is limited information regarding Off-Label Guideline-Supported Use of Pregabalin in adult patients.
Chronic Overdose
Pregabalin has potential for recreational use and abuse.citation needed It possesses a relatively wide therapeutic index and margin of safety compared to other central nervous system (CNS) depressants, and its effects may include euphoria, anxiolysis, and sedation. Pregabalin has potential for recreational use and abuse.citation needed It possesses a relatively wide therapeutic index and margin of safety compared to other central nervous system (CNS) depressants, and its effects may include euphoria, anxiolysis, and sedation. A tapered discontinuation is recommended to reduce the chances of withdrawal symptoms.